Full Contact Fighter Database

Home

>

News

>

Article

Media

Tuesday, Aug 22, 2017

Jon Jones Flagged For Potential Anti-Doping Policy Violation

Jon Jones (photo via UFC)

By FCF Staff

Less than a month out from his championship win at UFC 214, Jon Jones has been flagged for a potential anti-doping violation.

Jones fought Daniel Cormier at the July 29th event, and stopped now former light-heavyweight champ, Daniel Cormier. According to a report from TMZ, however, sources have told the outlet Jones has tested positive for turinabol, an anabolic steroid.

Recently the UFC posted the statement below:

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.

USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.

Additional information will be provided at the appropriate time as the process moves forward.

Jones recently completed a one year suspension he received from USADA, as a result of a positive test for clomiphene and Letrozol. Jones’ camp demonstrated that a sexual enhancement pill he had taken included the banned substances.

The 30 year-old Jones has been involved in several scandals now during his career, including a hit-and-run incident and a DUI.

posted by FCF Staff @ 9:27 pm
Have a comment about this story? Please share with us by filling out the fields below.

Comments are closed.